Macquarie Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Macquarie Group’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-8,600	Closed	-$167K	–	2355
2018 Q1	$167K	Buy	8,600 +6,500	+310%	+$128K	﹤0.01%	1762
2017 Q4	$35K	Buy	+2,100	New	+$38.5K	﹤0.01%	2052
2016 Q2	–	Sell	-89,939	Closed	-$2.88M	–	1672
2016 Q1	$2.88M	Buy	+89,939	New	+$3.16M	0.01%	855
2014 Q4	–	Sell	-50	Closed	-$1K	–	1648
2014 Q3	$1K	Buy	+50	New	+$1.28K	﹤0.01%	1546

Macquarie Group's IPXL Position: Q2 2018 in Review

Macquarie Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 8,600 shares — an estimated $167K sold.

Macquarie Group first reported a position in IPXL in Q3 2014 and held it in 4 quarters. The position peaked at $2.88M in Q1 2016. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Macquarie Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Macquarie Group sold 8,600 Impax Laboratories, Inc. shares in Q2 2018, an estimated $167K.
Macquarie Group first reported a position in Impax Laboratories, Inc. in Q3 2014 and held it in 4 quarters.
Macquarie Group's Impax Laboratories, Inc. position peaked at $2.88M in Q1 2016.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Macquarie Group's 13F filing for Q2 2018, filed 14 Aug 2018.